Fulya Akpinar Singh

Fulya is Senior Director at Genmab, where she leads the application of quantitative clinical pharmacology and model-informed approaches to support drug development across innovative therapeutics. With prior leadership roles at Bristol Myers Squibb, she brings extensive expertise in quantitative systems pharmacology, translational modelling, and clinical pharmacology, leveraging mechanistic and data-driven insights to inform decision-making from preclinical research through clinical development.